Calcium antagonists for acute ischemic heart disease.
The pharmacologic and physiologic effects of the slow-channel calcium antagonists verapamil, nifedipine and diltiazem are reviewed. Relevant pathophysiologic features of various acute ischemic heart disease syndromes are also reviewed and the clinical applications of the slow-channel calcium antagonists to acute ischemic heart disease syndromes in patients are discussed.
D000208:Acute Disease; D000788:Angina Pectoris, Variant / Q000188:drug therapy / Q000503:physiopathology; D000789:Angina, Unstable / Q000188:drug therapy / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology*; D004110:Diltiazem / Q000494:pharmacology; D004562:Electrocardiography; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000503:physiopathology; D009543:Nifedipine / Q000494:pharmacology; D013577:Syndrome; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine